Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ana Villegas
Observed names:
A Villegas,
A. Villegas,
Ana María Villegas,
Ana villegas,
Villegas A.
Institutions:
Universidad Complutense de Madrid,
Hospital Clínico San Carlos
Observed institutions:
Universidad Complutense de Madrid,
Hospital Clínico San Carlos,
Hospital Universitari i Politècnic La Fe,
Complejo Hospitalario de Jaén,
Spanish Society of Hematology and Hemotherapy,
Hospital Universitari Germans Trias i Pujol,
Instituto Nacional de la Salud
show all 7
ORCID:
0000-0003-3316-8953
Observed ORCID:
0000-0003-3316-8953
OpenAlex ID:
A5102924000
Healing of broken human chromosomes by the addition of telomeric repeats.
1994
·
J Flint
, C F Craddock
, et al.
·
PubMed
·
222
Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification
2012
·
P. Font
, J. Loscertales
, et al.
·
Annals of Hematology
·
99
Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts
2014
·
Patricia Font
, Javier Loscertales
, et al.
·
Annals of Hematology
·
92
Monosomy for the most telomeric, gene-rich region of the short arm of human chromosome 16 causes minimal phenotypic effects
2001
·
Sharon W Horsley
, Rachael J Daniels
, et al.
·
European Journal of Human Genetics
·
88
Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications
2014
·
On behalf of the IRON-2 Study Group
, Ángel F. Remacha
, et al.
·
Annals of Hematology
·
73
The Thalassemia Syndromes: Molecular Characterization in the Spanish Population
2001
·
Ana Villegas
, Paloma Ropero
, et al.
·
Hemoglobin
·
73
Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group.
1999
·
A F Remacha
, B Arrizabalaga
, et al.
·
PubMed
·
70
Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML‐RARα isoforms: a study of the PETHEMA group
2001
·
M. González
, E. Barragán
, et al.
·
British Journal of Haematology
·
69
PDF
Guidelines on haemovigilance of post-transfusional iron overload.
2013
·
Angel Remacha
, Cristina Sanz
, et al.
·
Europe PMC (PubMed Central)
·
62
A Search for Anomalies in the ζ,α,β, and γ Globin Gene Arrangements in Normal Black, Italian, Turkish, and Spanish Newborns
1989
·
Y. J. Fei
, F. Kutlar
, et al.
·
Hemoglobin
·
58
Paroxysmal nocturnal hemoglobinuria: a single S panish center's experience over the last 40 yr
2014
·
Cristina Muñoz‐Linares
, Emilio Ojeda
, et al.
·
European Journal Of Haematology
·
42
PDF
Improving safety in blood transfusion using failure mode and effect analysis
2019
·
Asunción Mora
, Luis Ayala
, et al.
·
Transfusion
·
38
Variability in the levels of PML-RAR alpha fusion transcripts detected by the laboratories participating in an external quality control program using several reverse transcription polymerase chain reaction protocols.
2001
·
P Bolufer
, F Lo Coco
, et al.
·
PubMed
·
36
GFI1B controls its own expression binding to multiple sites
2009
·
E. Anguita
, A. Villegas
, et al.
·
Haematologica
·
34
PDF
Darbepoetin alfa for anemia in patients with low or intermediate-1 risk myelodysplastic syndromes and positive predictive factors of response
2011
·
A. Villegas
, B. Arrizabalaga
, et al.
·
Current Medical Research and Opinion
·
32
Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements
2009
·
Angel F. Remacha
, Beatriz Arrizabalaga
, et al.
·
Annals of Hematology
·
32
Haemoglobinopathies with high oxygen affinity. Experience of Erythropathology Cooperative Spanish Group
2008
·
F. A. González Fernández
, A. Villegas
, et al.
·
Annals of Hematology
·
32
α Thalassaemia in two Spanish families
1990
·
A. Villegas
, F. Calero
, et al.
·
European Journal Of Haematology
·
27
Consenso español para el diagnóstico y tratamiento de la hemoglobinuria paroxística nocturna
2016
·
Ana Villegas
, Beatriz Arrizabalaga
, et al.
·
Medicina Clínica
·
25
Identification of the Hb Lepore phenotype by HPLC.
1999
·
P Ropero
, F A González
, et al.
·
PubMed
·
25
Presence of acute and chronic renal failure in patients with paroxysmal nocturnal hemoglobinuria: results of a retrospective analysis from the Spanish PNH Registry
2017
·
Ana Villegas
, Ramiro Núñez
, et al.
·
Annals of Hematology
·
24
Glutathione S-transferase M1 and T1 genetic polymorphisms are not related to the risk of hepatocellular carcinoma: A study in the Spanish population
2005
·
José M. Ladero
, Carmen Martínez
, et al.
·
European Journal of Cancer
·
24
Extravascular hemolysis and complement consumption in Paroxysmal Nocturnal Hemoglobinuria patients undergoing eculizumab treatment
2016
·
Marta Subías Hidalgo
, Hector Martin Merinero
, et al.
·
Immunobiology
·
22
PDF
An Electronic Infrastructure for Research and Treatment of the Thalassemias and Other Hemoglobinopathies: The Euro-Mediterranean Ithanet Project
2009
·
Carsten W. Lederer
, A. Nazli Basak
, et al.
·
Hemoglobin
·
22
Phenotype of mutations in the promoter region of the β-globin gene
2017
·
Paloma Ropero
, Sara Erquiaga
, et al.
·
Journal of Clinical Pathology
·
21
Show more works
View as search
Works count:
191
Citation count:
2,246
H-index:
22
I10-index:
57
Year
Topic
Type